BCTX — Briacell Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapSucker Stock

Annual balance sheet for Briacell Therapeutics, fiscal year end - July 31st, USD millions except per share, conversion factor applied.

	C2021 July 31st	2022 July 31st	2023 July 31st	2024 July 31st	2025 July 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	57.3	41	21.3	0.862	17.9
Net Total Accounts Receivable
Net Total Receivables	0.013	0.024	0.019	2.79	2.06
Prepaid Expenses
Total Current Assets	57.8	42.3	26.9	3.65	19.9
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	—	—	—	0.388	0.297
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	58	42.6	27.2	5.87	21.6
Accounts Payable
Payable / Accrued
Notes Payable / Short Term Debt
Total Current Liabilities	0.557	0.941	1.8	7.46	3.98
Long Term Debt
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Liabilities	30.4	32.2	30.9	8.25	3.77
Common Stock
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	27.7	10.3	-3.78	-2.38	17.9
Total Liabilities & Shareholders' Equity	58	42.6	27.2	5.87	21.6
Total Common Shares Outstanding